Skip to main content

Table 1 Patient characteristics according to the PET/CT SUVmax at different treatment time points

From: Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma

Variable Baseline SUVmax P value Mid-therapy SUVmax P value Post-therapy SUVmax P value
n Mean ± SD n Mean ± SD n Mean ± SD
Age    0.073    0.489    0.695
 <60 years 20 18.5 ± 8.5   13 4.1 ± 4.9   14 3.2 ± 3.9  
 ≥60 years 3 7.1 ± 2.6   2 6.3 ± 7.4   3 2.7 ± 4.6  
Sex    0.357    0.595    0.411
 Male 17 17.5 ± 8.5   11 4.0 ± 3.6   13 3.0 ± 2.6  
 Female 6 15.5 ± 10.3   4 5.3 ± 8.4   4 3.6 ± 7.3  
B symptoms    1.000    0.953    1.000
 Yes 8 17.7 ± 9.1   7 3.3 ± 3.0   8 2.7 ± 2.5  
 No 15 16.6 ± 9.0   8 5.3 ± 6.3   9 3.5 ± 5.0  
Bulky diseasea    0.069    0.293    0.164
 Yes 4 24.1 ± 5.6   3 1.8 ± 3.1   2 4.7 ± 0.6  
 No 19 15.5 ± 8.8   12 5.0 ± 5.2   15 2.9 ± 4.1  
ECOG scores    0.014    0.631    0.363
 <2 14 13.4 ± 7.6   9 5.2 ± 5.8   10 3.0 ± 4.8  
 ≥2 9 22.6 ± 8.0   6 3.1 ± 3.4   7 3.3 ± 2.4  
Ann arbor stage    0.068    0.674    0.111
 I–IIE 10 14.0 ± 10.5   6 4.6 ± 4.3   9 1.8 ± 2.8  
 III–IVE 13 19.4 ± 6.8   9 4.2 ± 5.6   8 4.7 ± 4.6  
LDH    0.156    0.262    0.618
 ≤245 12 14.9 ± 11.3   7 6.2 ± 6.3   8 3.5 ± 5.3  
 >245 11 19.3 ± 4.5   8 2.7 ± 3.0   9 3.0 ± 2.4  
IPI scores    0.114    0.368    0.176
 ≤2 14 15.0 ± 9.9   9 5.5 ± 5.8   11 2.8 ± 4.6  
 >2 9 20.2 ± 6.1   6 2.7 ± 3.1   6 3.8 ± 2.2  
  1. PET positron emission tomography, CT computed tomography, SUVmax the maximum standardized uptake value, ECOG eastern cooperative oncology group, LDH lactate dehydrogenase, IPI international prognostic index, SD standard deviation
  2. aBulky disease, tumor diameter >10 cm